Hai Zheng Pharmaceutical: Controlling subsidiary plans to set up a joint venture with an investment of 50 million yuan and invest in a new project.

Haizheng Pharmaceuticals announced that its controlling subsidiary Haizheng Dongbao plans to jointly establish Zhejiang Haizheng Zhongyu Animal Nutrition Technology Co., Ltd. with Zhongyu Pet Food, with a registered capital of 50 million yuan. Haizheng Dongbao will contribute 30 million yuan in equity and cash, accounting for 60%, while Zhongyu Pet Food will contribute 20 million yuan in cash, accounting for 40%. The joint venture company will engage in the pet prescription food business, and both parties have also made provisions for capital increase and corporate governance. In addition, the company's wholly-owned subsidiary Zhejiang Yunsheng Synthetic Biology Technology Co., Ltd. has launched the "Industrial Cooperative Upgrade Project," with a total planned investment of 497 million yuan, applying for a loan of 334 million yuan, and a construction period of 4 years.